Noninvasive Ventilation and Oxygenation Strategies

“…Meanwhile, Nair et al. 18 pointed out that using NIV to the patient of COVID-19 pneumonia should carefully monitor to avoid delaying in endotracheal intubation. But other study pointed out that the use of NIV had proven helpful when the global pandemic of COVID-19 20 , 21 .…”

Section: Discussionmentioning

confidence: 99%

Azvudine reduces the in-hospital mortality of COVID-19 patients: A retrospective cohort study

Zong

Zhou

Wen

et al. 2023

Acta Pharmaceutica Sinica B

View full text Add to dashboard Cite

“…Furthermore, for each patient, we evaluated admittance to a high-intensity care unit, where invasive mechanical ventilation or bi-level positive airway pressure, continuous positive airway pressure, and high-flow nasal cannula oxygen therapy was provided [10]; admittance to a medium-intensity care ward, where non-invasive respiratory support, such as a nasal cannula, simple mask, non-rebreather, or Venturi mask was provided [11]. We focused our analysis on mortality due to COVID-19 as a primary outcome.…”

Section: Methodsmentioning

confidence: 99%

Is Previous eGFR a Reliable Risk Factor for COVID-19 Death? Single Centre Analysis in Chronic Kidney Disease Patients in Northern Italy

Martino

Fanton

Zanetti

et al. 2022

BioMed

View full text Add to dashboard Cite

COVID-19 remains a major world health problem, and its clinical manifestations can vary from an oligosymptomatic form to severe pulmonary infection, which can require invasive ventilation and is strictly related to death. Identifying risk factors for adverse outcomes is essential for performing adequate care and contrasting high mortality. Chronic kidney disease (CKD) is a widespread comorbidity and is a known risk factor for death during SARS-CoV-2 infection. The present study evaluates the death risk assessment during the COVID-19 pandemic in (CKD) patients, considering the baseline value of an estimated glomerular filtration rate (eGFR) and other possible risk factors. We retrospectively assessed the mortality risk in 150 patients with COVID-19 between 1 October and 31 December 2020. We evaluated eGFR, haemoglobin, albumin, uric acid, cholesterol, triglycerides, and significant risk factors, such as diabetes mellitus and cardiovascular disease in every patient. We had 53 deaths (35.3%) during the observational period, significantly related to age, eGFR, albumin, and baseline nephropathy. In the multivariable analysis, only baseline eGFR and age were independent predictors of death during SARS-CoV-2 infection, with an OR equal to 0.96 and 1.067, respectively. In conclusion, by our analysis, age, and the baseline eGFR were the only reliable predictors of death during COVID-19 in CKD patients.

show abstract

“…Modern oxygen delivery methods incorporate therapies like CPAP and BPAP into noninvasive ventilation (NIV). Continuous positive airway pressure (CPAP) therapy is a method used to provide a continuous level of PEEP during both inspiration and expiration, thus increasing the patient's FRC [ 94 ]. Bilevel positive airway pressure (BPAP) therapy uses a pressure cycling mode for delivering NIV [ 94 ].…”

Section: Reviewmentioning

confidence: 99%

Management of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Hospitalized Patients From Admission to Discharge: A Comprehensive Review of Therapeutic Interventions

Khan,

Jawaid,

Memon

et al. 2023

Cureus

View full text Add to dashboard Cite

Chronic obstructive pulmonary disease (COPD) is a common and debilitating condition that often necessitates hospitalization for exacerbations. Since COPD exacerbations can cause significant morbidity and mortality, managing them is crucial for patient care. Effective management of COPD exacerbations is essential to prevent complications, as COPD exacerbations are associated with increased healthcare costs and decreased quality of life. This review aims to comprehensively discuss the management of COPD exacerbations, covering various pharmacologic and non-pharmacologic strategies. These include inhaled bronchodilators, systemic steroids, antibiotics, invasive and non-invasive ventilation, oxygen therapy, smoking cessation, immunization with pneumococcal vaccine, inhalers at discharge, pulmonary rehabilitation, long-term oxygen therapy (LTOT), ambulatory oxygen therapy, short-burst oxygen therapy, extracorporeal membrane oxygenation (ECMO), lung volume reduction surgery (LVRS), endobronchial procedures, and lung transplant. It is drawn upon various sources, including clinical studies, systemic reviews, and observational studies, to provide a comprehensive overview of current practices and identify areas for future research and innovation in managing COPD exacerbations. Addressing these areas of interest can improve patient outcomes and quality of life.

show abstract

Noninvasive Ventilation and Oxygenation Strategies

Cited by 17 publications

References 45 publications

Azvudine reduces the in-hospital mortality of COVID-19 patients: A retrospective cohort study

Azvudine reduces the in-hospital mortality of COVID-19 patients: A retrospective cohort study

Is Previous eGFR a Reliable Risk Factor for COVID-19 Death? Single Centre Analysis in Chronic Kidney Disease Patients in Northern Italy

Management of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Hospitalized Patients From Admission to Discharge: A Comprehensive Review of Therapeutic Interventions

Contact Info

Product

Resources

About